Współczesna Onkologia

Full text

3/2025 vol. 29

Correction for: Accelerated chronic lymphocytic leukemia – characteristics and retrospective analysis of the Polish Adult Leukemia Study Group

  1. Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa, Poland
  2. Department of General Hematology, Copernicus Memorial Hospital in Łódź, Medical University, Łódź, Poland
  3. Department of Hematology, Medical University, Łódź, Poland
  4. Department of Hematooncology, Copernicus Memorial Hospital, Łódź, Poland
  5. Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA
  6. Department of Hematology, Transplantation and Internal Medicine, Medical University, Warszawa, Poland
  7. Hematology Department, St John’s Cancer Centre, Lublin, Poland
  8. Department of Hematology, Institute of Medical Sciences, University of Opole, Opole, Poland
  9. Department of Hematology and Transplantology, Medical University, Gdańsk, Poland
  10. Department of Internal Diseases and Oncological Chemotherapy, Faculty of Medical Sciences, Medical University of Silesia, Katowice, Poland
  11. Department of Lymphoid Malignancies, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland
  12. Department of Hematooncology and Bone Marrow Transplantation, Medical University, Lublin, Poland
  13. Hematology Department, Institute of Medical Sciences, College of Medical Sciences, University, Rzeszów, Poland
  14. Department of Hematology, Provincial Hospital, Szczecin, Poland
  15. Department of Pathology, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland
  16. Biobank, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa,Poland
  17. Diagnostic Hematology Department, Institute of Hematology and Transfusion Medicine, Warszawa, Poland
  18. Department of Pathology, Chair of Oncology, Medical University, Łódź, Poland
  19. Department of Pathomorphology, University Clinical Centre, Medical University, Warszawa, Poland
Contemp Oncol (Pozn) 2025; 29 (3): 320-321
Data publikacji online: 2025/09/17
Article file
Correction for Accelerated.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

The authors of the article [1] have advised that there is an errors:

In Figure 2, the legend describing the curves representing the results has been changed, which notably alters the meaning of the results and may be misleading.

Fig. 2

Overall survival (A) and progression-free survival (B) in treatment-naive accelerated chronic lymphocytic leukemia patients treated with fludarabine vs. other treatment regimens

OS – overall survival, PFS – progression-free survival

/f/fulltexts/WO/56653/WO-29-56653-g001_min.jpg

Correct Fig. 2.

Fig. 2

Overall survival (A) and progression-free survival (B) in treatment-naive accelerated chronic lymphocytic leukemia patients treated with fludarabine vs. other treatment regimens

OS – overall survival, PFS – progression-free survival

/f/fulltexts/WO/56653/WO-29-56653-g002_min.jpg

It was wrongly given as:

The article has since been corrected online.

References

1 

Sośnia O, Iskierka-Jażdżewska E, Puła A, et al. Accelerated chronic lymphocytic leukemia–characteristics and retrospective analysis of the Polish Adult Leukemia Study Group. Contemp Oncol (Pozn) 2025; 29 (1): 63–70, DOI: 10.5114/mp.2025.148753.

Copyright: © 2025 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees